Chromosome 5 monosomy of Candida albicans controls susceptibility to various toxic agents, including major antifungals

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 10, 2013, Pages 5026-5036

  Yang, Feng ^a   Kravets, Anatoliy ^a   Bethlendy, Gabor ^b,c   Welle, Stephen ^a   Rustchenko, Elena ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Roche Diagnostics Corporation   (United States)

^c Parabase Genomics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; CHITIN; CHITIN SYNTHASE; CHITINASE; ECHINOCANDIN; ERGOSTEROL; FLUCONAZOLE; FLUCYTOSINE; GLUCAN; SORBOSE;

ADAPTATION; ARTICLE; CANDIDA ALBICANS; CELL WALL; CHROMOSOME 5; DOWN REGULATION; FUNGAL STRAIN; MONOSOMY; PHENOTYPE; PRIORITY JOURNAL; STRESS; UPREGULATION; WILD TYPE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CHROMOSOMES, FUNGAL; ECHINOCANDINS; FLUCONAZOLE; FLUCYTOSINE;

EID: 84884222468     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00516-13     Document Type: Article

References (62)

1. Rustchenko E, Sherman F. 2003. Genetic instability of Candida albicans, p 723-776. In Howard DH, Fungi pathogenic for humans and animals, 2nd ed. Marcel Dekker, Inc., New York, NY.
2. Rustchenko E. 2007. Chromosome instability in Candida albicans. FEMS Yeast Res. 7:2-11.
3. Rustchenko E. 2008. Specific chromosome alterations of Candida albicans: mechanism for adaptation to pathogenicity, p 197-212. In Nombela C, Cassel G, Baquero F, Gutíerrez-Fuentes J (ed), Evolutionary biology of bacterial and fungal pathogens. ASM Press, Washington, DC.
4. Ahmad A, Kabir MA, Kravets A, Andaluz E, Larriba G, Rustchenko E. 2008. Chromosome instability and unusual features of some widely used strains of Candida albicans. Yeast 25:433-448.
5. Selmecki A, Forche A, Berman J. 2010. Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryot. Cell 9:991-1008.
6. Coste AT, Karababa M, Ischer F, Bille J, Sanglard D. 2004. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot. Cell 3:1639-1652.
7. Diogo D, Bouchier C, d'Enfert C, Bougnoux ME. 2009. Loss of heterozygosity in commensal isolates of the asexual diploid yeast Candida albicans. Fungal Genet. Biol. 46:159-168.
8. Legrand M, Lephart P, Forche A, Mueller FM, Walsh T, Magee PT, Magee BB. 2004. Homozygosity at the MTL locus in clinical strains of Candida albicans: karyotypic rearrangements and tetraploid formation. Mol. Microbiol. 52:1451-1462.
9. Selmecki A, Forche A, Berman J. 2006. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 313:367-370.
10. Selmecki A, Gerami-Nejad M, Paulson C, Forche A, Berman J. 2008. An isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1. Mol. Microbiol. 68:624-641.
11. Janbon G, Sherman F, Rustchenko E. 1998. Monosomy of a specific chromosome determines L-sorbose utilization: a novel regulatory mechanism in Candida albicans. Proc. Natl. Acad. Sci. U. S. A. 95:5150-5155.
12. Janbon G, Sherman F, Rustchenko E. 1999. Appearance and properties of L-sorbose-utilizing mutants of Candida albicans obtained on a selective plate. Genetics 153:653-664.
13. Greenberg JR, Price NP, Oliver RP, Sherman F, Rustchenko E. 2005. Candida albicans SOU1 encodes a sorbose reductase required for L-sorbose utilization. Yeast 22:957-969.
14. Ahmad A, Kravets A, Rustchenko E. 2012. Transcriptional regulatory circuitries in the human pathogen Candida albicans involving senseantisense interactions. Genetics 190:537-547.
15. Kravets A, Qin H, Ahmad A, Bethlendy G, Gao Q, Rustchenko E. 2010. Widespread occurrence of dosage compensation in Candida albicans. PLoS One 5:e10856. doi:10.1371/journal.pone.0010856.
16. Mahadevan PR, Tatum EL. 1965. Relationship of the major constituents of the Neurospora crassa cell wall to wild-type and colonial morphology. J. Bacteriol. 90:1073-1081.
17. Crocken B, Tatum EL. 1968. The effect of sorbose on metabolism and morphology of Neurospora. Biochim. Biophys. Acta 156:1-8.
18. Elorza MV, Arst HN, Jr. 1971. Sorbose resistant mutants of Aspergillus nidulans. Mol. Gen. Genet. 111:185-193.
19. Mishra NC, Tatum EL. 1972. Effect of L-sorbose on polysaccharide synthetases of Neurospora crassa. Proc. Natl. Acad. Sci. U. S. A. 69:313-317.
20. Kurtz MB, Abruzzo G, Flattery A, Bartizal K, Marrinan JA, Li W, Milligan J, Nollstadt K, Douglas CM. 1996. Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect. Immun. 64:3244-3251.
21. Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H. 2006. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin. Antimicrob. Agents Chemother. 50:3160-3161.
22. Balashov SV, Park S, Perlin DS. 2006. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1. Antimicrob. Agents Chemother. 50:2058-2063.
23. Rustchenko-Bulgac EP, Sherman F, Hicks JB. 1990. Chromosomal rearrangements associated with morphological mutants provide a means for genetic variation of Candida albicans. J. Bacteriol. 172:1276-1283.
24. Rustchenko EP, Howard DH, Sherman F. 1994. Chromosomal alterations of Candida albicans are associated with the gain and loss of assimilating functions. J. Bacteriol. 176:3231-3241.
25. Sherman F. 2002. Getting started with yeast. Methods Enzymol. 350: 3-41.
26. Wellington M, Rustchenko E. 2005. 5-Fluoro-orotic acid induces chromosome alterations in Candida albicans. Yeast 22:57-70.
27. Clinical and Laboratory Standards Institute. 2008. M27-A3 reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, 3rd ed. Clinical and Laboratory Standards Institute, Wayne, PA.
28. Munro CA, Selvaggini S, de Bruijn I, Walker L, Lenardon MD, Gerssen B, Milne S, Brown AJ, Gow NA. 2007. The PKC, HOG and Ca2signalling pathways coordinately regulate chitin synthesis in Candida albicans. Mol. Microbiol. 63:1399-1413.
29. Shedletzky E, Unger C, Delmer DP. 1997. A microtiter-based fluorescence assay for (1,3)-beta-glucan synthases. Anal. Biochem. 249:88-93.
30. Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. 1999. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J. Clin. Microbiol. 37:3332-3337.
31. Young LY, Hull CM, Heitman J. 2003. Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob. Agents Chemother. 47:2717-2724.
32. Muir A, Harrison E, Wheals A. 2011. A multiplex set of species-specific primers for rapid identification of members of the genus Saccharomyces. FEMS Yeast Res. 11:552-563.
33. Schuetzer-Muehlbauer M, Willinger B, Krapf G, Enzinger S, Presterl E, Kuchler K. 2003. The Candida albicans Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin. Mol. Microbiol. 48: 225-235.
34. Rustad TR, Stevens DA, Pfaller MA, White TC. 2002. Homozygosity at the Candida albicans MTL locus associated with azole resistance. Microbiology 148:1061-1072.
35. Pujol C, Messer SA, Pfaller M, Soll DR. 2003. Drug resistance is not directly affected by mating type locus zygosity in Candida albicans. Antimicrob. Agents Chemother. 47:1207-1212.
36. Kabir MA, Ahmad A, Greenberg JR, Wang YK, Rustchenko E. 2005. Loss and gain of chromosome 5 controls growth of Candida albicans on sorbose due to dispersed redundant negative regulators. Proc. Natl. Acad. Sci. U. S. A. 102:12147-12152.
37. Rustchenko-Bulgac EP. 1991. Variations of Candida albicans electrophoretic karyotypes. J. Bacteriol. 173:6586-6596.
38. Moreno I, Pedreno Y, Maicas S, Sentandreu R, Herrero E, Valentin E. 2003. Characterization of a Candida albicans gene encoding a putative transcriptional factor required for cell wall integrity. FEMS Microbiol. Lett. 12:159-167.
39. Ritch JJ, Davidson SM, Sheehan JJ, Austriaco N. 2010. The Saccharomyces SUN gene, UTH1, is involved in cell wall biogenesis. FEMS Yeast. Res. 10:168-176.
40. De Nobel JG, Klis FM, Ram A, Van Unen H, Priem J, Munnik T, Van Den Ende H. 1991. Cyclic variations in the permeability of the cell wall of Saccharomyces cerevisiae. Yeast 7:589-598.
41. Klippel N, Cui S, Groebe L, Bilitewski U. 2010. Deletion of the Candida albicans histidine kinase gene CHK1 improves recognition by phagocytes through an increased exposure of cell wall beta-1,3-glucans. Microbiology 156:3432-3444.
42. Kitamura K, Yamamoto Y. 1972. Purification and properties of an enzyme, zymolyase, which lyses viable yeast cells. Arch. Biochem. Biophys. 153:403-406.
43. Loeffler J, Stevens DA. 2003. Antifungal drug resistance. Clin. Infect. Dis. 36(Suppl. 1):S31-S41.
44. Walker LA, Munro CA, de Bruijn I, Lenardon MD, McKinnon A, Gow NA. 2008. Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog. 4:e1000040. doi:10.1371/journal.ppat .1000040.
45. Shapiro RS, Robbins N, Cowen LE. 2011. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 75:213-267.
46. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O. 2012. Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg. Infect. Dis. 18:86-90.
47. Perlin DS. 2007. Resistance to echinocandin-class antifungal drugs. Drug Resist. Updat. 10:121-130.
48. Dodgson AR, Dodgson KJ, Pujol C, Pfaller MA, Soll DR. 2004. Cladespecific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans. Antimicrob. Agents Chemother. 48:2223-2227.
49. Quigley D, Selitrennikoff C. 1984. (1-3)Glucan synthase of Neurosporn crassa: kinetic analysis of negative regulators. Exp. Mycol. 8:320-333.
50. Sanz M, Carrano L, Jimenez C, Candiani G, Trilla JA, Duran A, Roncero C. 2005. Candida albicans strains deficient in CHS7, a key regulator of chitin synthase III, exhibit morphogenetic alterations and attenuated virulence. Microbiology 151:2623-2636.
51. Trilla JA, Duran A, Roncero C. 1999. Chs7p, a new protein involved in the control of protein export from the endoplasmic reticulum that is specifically engaged in the regulation of chitin synthesis in Saccharomyces cerevisiae. J. Cell Biol. 145:1153-1163.
52. Kaneko Y, Ohno H, Kohno S, Miyazaki Y. 2010. Micafungin alters the expression of genes related to cell wall integrity in Candida albicans biofilms. Jpn. J. Infect. Dis. 63:355-357.
53. Drakulovski P, Dunyach C, Bertout S, Reynes J, Mallie M. 2011. A Candida albicans strain with high MIC for caspofungin and no FKS1 mutations exhibits a high chitin content and mutations in two chitinase genes. Med. Mycol. 49:467-474.
54. Wang YK, Das B, Huber DH, Wellington M, Kabir MA, Sherman F, Rustchenko E. 2004. Role of the 14-3-3 protein in carbon metabolism of the pathogenic yeast Candida albicans. Yeast 21:685-702.
55. Rustchenko EP, Curran TM, Sherman F. 1993. Variations in the number of ribosomal DNA units in morphological mutants and normal strains of Candida albicans and in normal strains of Saccharomyces cerevisiae. J. Bacteriol. 175:7189-7199.
56. Lee KK, Maccallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NA, Munro CA. 2012. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo. Antimicrob. Agents Chemother. 56:208-217.
57. Plaine A, Walker L, Da Costa G, Mora-Montes HM, McKinnon A, Gow NA, Gaillardin C, Munro CA, Richard ML. 2008. Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. Fungal Genet. Biol. 45:1404-1414.
58. Jimenez-Ortigosa C, Aimanianda V, Muszkieta L, Mouyna I, Alsteens D, Pire S, Beau R, Krappmann S, Beauvais A, Dufrene YF, Roncero C, Latge JP. 2012. Chitin synthases with a myosin motor-like domain control the resistance of Aspergillus fumigatus to echinocandins. Antimicrob. Agents Chemother. 56:6121-6131.
59. Balkis MM, Leidich SD, Mukherjee PK, Ghannoum MA. 2002. Mechanisms of fungal resistance: an overview. Drugs 62:1025-1040.
60. Hitchcock CA, Dickinson K, Brown SB, Evans EG, Adams DJ. 1990. Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans. Biochem. J. 266:475-480.
61. Ji H, Zhang W, Zhou Y, Zhang M, Zhu J, Song Y, Lu J. 2000. A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals. J. Med. Chem. 43:2493-2505.
62. Wirsching S, Michel S, Morschhauser J. 2000. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol. Microbiol. 36:856-865.